Reports
Reports
Sale
The global lithotripsy devices market size was valued at USD 1.6 billion in 2023, driven by the surge in kidney stones cases and preference for minimally invasive procedures across the globe. The market is expected to grow at a CAGR of 5.7% during the forecast period of 2024-2032, with the values likely to rise from USD 1.7 billion in 2024 to USD 2.6 billion by 2032.
A lithotripsy device is used to treat kidney stones by breaking larger stones into smaller ones, facilitating an easy passage through the urinary tract. It involves using electromagnetic shock waves or ultrasonic energy, which travels through the skin and tissue, reaching the stone to break it.
Lithotripsy devices are used in a non-invasive procedure called lithotripsy, used in treating ureteral stones, pancreatic stones, bile duct stones, in addition to kidney stones.
With the rising incidence of kidney stones diseases worldwide, the volume of minimally invasive endourological procedures has seen an upswing. As a result, lithotripsy devices market demand has increased.
Holmium lasers have been used to treat ablate all stone types. Holmium: yttrium–aluminum–garnet (Ho:YAG) relies on a photothermal effect for stone breakage. Although, holmium laser technology has been widely used for ureteroscopy lithotripsy currently, thulium fiber lasers have flourished in the market. Thulium fibre delivers energy through a flexible optical fibre. The fibre uses a highly thermal ablative effect. It allows a wider range of laser setting with potentially low energy consumption and high frequencies. It also leads to higher ablation speed for any stone composition.
The lithotripsy devices market growth is certain with the current transition from fibre optic to digital systems. It enables an improved vision for the healthcare provider. Laser interaction with image sensor causes acoustic shockwaves, which leads to image flickering. Therefore, several modifications have been made to improve the system with a digital system enabling.
As per the new developments, miniaturized devices are preferred owing to their advantages of lower insertion failure rates, better irrigation outflow, and lower risk of ureteral damage. Uscope 3022 (Pusen™) is the latest slimmest and single use ureteroscopes available. With the continuous incoming of digitally integrated high technology devices, the market is anticipated to witness further growth in the coming years.
Market Breakup by Device Type
Market Breakup by Application
Market Breakup by End User
Market Breakup by Region
Kidney stone is a major cause of morbidity, affecting around 1-15% of the world’s population. Conditions like hypertension, diabetes, and fatty liver have been identified as some of the common risk factors of the disease. It affects both the sexes, which increases it occurrence to affect around 7-15% in the North American population. As a result, it is likely to contribute significantly to the lithotripsy devices market share. North America possesses a robust healthcare system which is super-efficient to treat illness by developing new technologies. The presence of leading healthcare companies is another reason for the notable market share.
The Asia Pacific region is estimated to observe rapid growth in the forecast period. The increased lithotripsy devices market value can be linked to high kidney stone cases in a geriatric population. This is because the risk of kidney stones increases with age. Moreover, the region is being subjected to various healthcare infrastructure developments, owing to foreign investments and government initiatives. Therefore, the market size is expected to grow exponentially in the coming years.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Device Type |
|
Breakup by Application |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Lithotripsy Devices Market Overview
3.1 Global Lithotripsy Devices Market Historical Value (2017-2023)
3.2 Global Lithotripsy Devices Market Forecast Value (2024-2032)
4 Global Lithotripsy Devices Market Landscape
4.1 Global Lithotripsy Devices Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Lithotripsy Devices Product Landscape
4.2.1 Analysis by Device Type
4.2.2 Analysis by Application
5 Global Lithotripsy Devices Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Lithotripsy Devices Market Segmentation
6.1 Global Lithotripsy Devices Market by Device Type
6.1.1 Market Overview
6.1.2 Extracorporeal Shock Wave Lithotripsy (ESWL)
6.1.3 Intracorporeal Lithotripsy
6.1.3.1 Ultrasonic Lithotripsy Devices
6.1.3.2 Electrohydraulic Lithotripsy Devices
6.1.3.3 Mechanical Lithotripsy Devices
6.1.3.4 Laser Lithotripsy Devices
6.2 Global Lithotripsy Devices Market by Application
6.2.1 Market Overview
6.2.2 Kidney Stones
6.2.3 Ureteral Stones
6.2.4 Pancreatic Stones
6.2.5 Bile Duct Stones
6.2.6 Others
6.3 Global Lithotripsy Devices Market by End User
6.3.1 Market Overview
6.3.2 Hospitals
6.3.3 Ambulatory Surgical Centres
6.3.4 Others
6.4 Global Lithotripsy Devices Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Lithotripsy Devices Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Lithotripsy Devices Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Lithotripsy Devices Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Lithotripsy Devices Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Lithotripsy Devices Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by Year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding & Investment Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Supplier Landscape
16.1 Becton, Dickinson and Company
16.1.1 Financial Analysis
16.1.2 Product Portfolio
16.1.3 Demographic Reach and Achievements
16.1.4 Mergers and Acquisitions
16.1.5 Certifications
16.2 DirexGroup
16.2.1 Financial Analysis
16.2.2 Product Portfolio
16.2.3 Demographic Reach and Achievements
16.2.4 Mergers and Acquisitions
16.2.5 Certifications
16.3 Richard Wolf GmbH
16.3.1 Financial Analysis
16.3.2 Product Portfolio
16.3.3 Demographic Reach and Achievements
16.3.4 Mergers and Acquisitions
16.3.5 Certifications
16.4 KARL STORZ SE & Co. KG
16.4.1 Financial Analysis
16.4.2 Financial Portfolio
16.4.3 Demographic Reach and Achievements
16.4.4 Mergers and Acquisitions
16.4.5 Certifications
16.5 Lumenis Be Ltd.
16.5.1 Financial Analysis
16.5.2 Product Portfolio
16.5.3 Demographic Reach and Achievements
16.5.4 Mergers and Acquisitions
16.5.5 Certifications
16.6 Verdict Media Limited
16.6.1 Financial Analysis
16.6.2 Product Portfolio
16.6.3 Demographic Reach and Achievements
16.6.4 Mergers and Acquisitions
16.6.5 Certifications
16.7 Dornier MedTech.
16.7.1 Financial Analysis
16.7.2 Product Portfolio
16.7.3 Demographic Reach and Achievements
16.7.4 Mergers and Acquisitions
16.7.5 Certifications
16.8 Siemens
16.8.1 Financial Analysis
16.8.2 Product Portfolio
16.8.3 Demographic Reach and Achievements
16.8.4 Mergers and Acquisitions
16.8.5 Certifications
16.9 Bio-Rad Laboratories Inc.
16.9.1 Financial Analysis
16.9.2 Product Portfolio
16.9.3 Demographic Reach and Achievements
16.9.4 Mergers and Acquisitions
16.9.5 Certifications
16.10 Enzo Biochem Inc
16.10.1 Financial Analysis
16.10.2 Product Portfolio
16.10.3 Demographic Reach and Achievements
16.10.4 Mergers and Acquisitions
16.10.5 Certifications
16.11 Trivitron Healthcare
16.11.1 Financial Analysis
16.11.2 Product Portfolio
16.11.3 Demographic Reach and Achievements
16.11.4 Mergers and Acquisitions
16.11.5 Certifications
16.12 Shenzhen New Industries Biomedical Engineering Co., Ltd.
16.12.1 Financial Analysis
16.12.2 Product Portfolio
16.12.3 Demographic Reach and Achievements
16.12.4 Mergers and Acquisitions
16.12.5 Certifications
16.13 Sinduri Biotec
16.13.1 Financial Analysis
16.13.2 Product Portfolio
16.13.3 Demographic Reach and Achievements
16.13.4 Mergers and Acquisitions
16.13.5 Certifications
16.14 STORZ MEDICAL AG
16.14.1 Financial Analysis
16.14.2 Product Portfolio
16.14.3 Demographic Reach and Achievements
16.14.4 Mergers and Acquisitions
16.14.5 Certifications
16.15 Boston Scientific Corporation
16.15.1 Financial Analysis
16.15.2 Product Portfolio
16.15.3 Demographic Reach and Achievements
16.15.4 Mergers and Acquisitions
16.15.5 Certifications
16.16 Olympus Corporation
16.16.1 Financial Analysis
16.16.2 Product Portfolio
16.16.3 Demographic Reach and Achievements
16.16.4 Mergers and Acquisitions
16.16.5 Certifications
17 Global Lithotripsy Devices Market - Distribution Model (Additional Insight)
17.1 Overview
17.2 Potential Distributors
17.3 Key Parameters for Distribution Partner Assessment
18 Key Opinion Leaders (KOL) Insights (Additional Insight)
19 Company Competitiveness Analysis (Additional Insight)
19.1 Very Small Companies
19.2 Small Companies
19.3 Mid-Sized Companies
19.4 Large Companies
19.5 Very Large Companies
20 Payment Methods (Additional Insight)
20.1 Government Funded
20.2 Private Insurance
20.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
The market attained a value of about USD 1.6 billion in 2023, driven by the incidence of kidney stones across the globe.
The market is anticipated to grow at a CAGR of 5.7% during the forecast period of 2024-2032, likely to reach a market value of USD 2.5 billion by 2032.
The prevalence of underlying diseases such as a fatty liver, diabetes, hypertension as well as obesity has increased occurrence of kidney stones. This has led to an increased lithotripsy treatment, leading to high demand for the device.
There has been a transition from fibre optic to digital system integrated devices in the market. Such devices include Uscope 3022 (Pusen™) and offer lower insertion failure rates, better irrigation outflow, and lower risk of ureteral damage.
Common application areas include kidney stones, ureteral stones, pancreatic stones, bile duct stones and others.
Major products include extracorporeal shock wave lithotripsy (ESWL) and intracorporeal lithotripsy, wherein intracorporeal lithotripsy is further segmented into ultrasonic lithotripsy devices, electrohydraulic lithotripsy devices, mechanical lithotripsy devices and laser lithotripsy devices.
Major end users include hospitals, clinics, and ambulatory surgical centres, among others.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is currently leading the global market.
Key players involved in the market are Becton, Dickinson and Company, DirexGroup, Richard Wolf GmbH, KARL STORZ SE & Co. KG, Lumenis Be Ltd., Verdict Media Limited, Dornier MedTech., Siemens, Bio-Rad Laboratories Inc., Enzo Biochem Inc, Trivitron Healthcare, Shenzhen New Industries Biomedical Engineering Co., Ltd., Sinduri Biotec, STORZ MEDICAL AG, Boston Scientific Corporation, and Olympus Corporation.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.